Cargando…

Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?

Hepatocellular carcinoma (HCC) is a common and deadly malignancy. The disease usually develops on a background of chronic liver disease. Until recently, the most common etiology was infection with the hepatitis C virus (HCV). The advent of direct-acting antiviral (DAA) therapies has been a major bre...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meringer, Hadar, Shibolet, Oren, Deutsch, Liat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2019
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6689810/ https://www.ncbi.nlm.nih.gov/pubmed/31413528 http://dx.doi.org/10.3748/wjg.v25.i29.3929

Ejemplares similares

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017)

Thrombocytopenia after liver transplantation: Should we care?
por: Takahashi, Kazuhiro, et al.
Publicado: (2018)

Immunity to SARS-CoV-2: What Do We Know and Should We Be Testing for It?
por: Misra, Anisha, et al.
Publicado: (2022)

Hepatitis C virus micro-elimination: Where do we stand?
por: Mangia, Alessandra, et al.
Publicado: (2021)

Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022)

Brugada type 1 electrocardiogram: Should we treat the electrocardiogram or the patient?
por: Delise, Pietro, et al.
Publicado: (2017)

When should we perform colonoscopy to increase the adenoma detection rate?
por: Kim, Sang Hoon, et al.
Publicado: (2021)

Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
por: Irshad, Mohammad, et al.
Publicado: (2017)

Cardiovascular assessment in liver transplant for non-alcoholic steatohepatitis patients: What we do, what we should do
por: Sanchez-Torrijos, Yolanda, et al.
Publicado: (2017)

Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
por: Gnyawali, Bipul, et al.
Publicado: (2022)

Advanced imaging and artificial intelligence for Barrett's esophagus: What we should and soon will do
por: Spadaccini, Marco, et al.
Publicado: (2022)

Host-pathogen studies in the post-genomic era
por: Kellam, Paul
Publicado: (2000)

Older age, longer procedures and tandem endoscopic-ultrasound as risk factors for post-endoscopic retrograde cholangiopancreatography bacteremia
por: Deutsch, Liat, et al.
Publicado: (2020)

Endoscopic ultrasound-guided biliary drainage: A change in paradigm?
por: Leung Ki, En-Ling, et al.
Publicado: (2019)

Should we initiate vasopressors earlier in patients with septic shock: A mini systemic review
por: Zhou, Hang-Xiang, et al.
Publicado: (2023)

Prospect of lenvatinib for unresectable hepatocellular carcinoma in the new era of systemic chemotherapy
por: Sho, Takuya, et al.
Publicado: (2021)

Elastography as a predictor of liver cirrhosis complications after hepatitis C virus eradication in the era of direct-acting antivirals
por: Cerrito, Lucia, et al.
Publicado: (2021)

Emergency department targeted screening for hepatitis C does not improve linkage to care
por: Houri, Inbal, et al.
Publicado: (2020)

With increasing trends of prostate cancer in the Saudi Arabia and Arab World: Should we start screening programs?
por: Arafa, Mostafa A, et al.
Publicado: (2017)

Liver transplantation for hepatocellular carcinoma: Where do we stand?
por: Santopaolo, Francesco, et al.
Publicado: (2019)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Era of direct acting anti-viral agents for the treatment of hepatitis C
por: Ahmed, Monjur
Publicado: (2018)

Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review
por: Gigi, Eleni, et al.
Publicado: (2018)

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
por: Muzica, Cristina Maria, et al.
Publicado: (2020)

CO-releasing Metal Carbonyl Compounds as Antimicrobial Agents in the Post-antibiotic Era
por: Wareham, Lauren K., et al.
Publicado: (2015)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
por: Kamal, Ahmed, et al.
Publicado: (2022)

Surgical treatment of hepatocellular carcinoma in the era of COVID-19 pandemic: A comprehensive review of current recommendations
por: Fancellu, Alessandro, et al.
Publicado: (2021)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
por: Lee, Hye Won, et al.
Publicado: (2016)

Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
por: Guo, Jiang, et al.
Publicado: (2021)

Gastrointestinal post-acute COVID-19 syndrome
por: Meringer, Hadar, et al.
Publicado: (2022)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Regulation of specialised metabolites in Actinobacteria – expanding the paradigms
por: Hoskisson, Paul A., et al.
Publicado: (2018)

Shift in the paradigm towards next-generation microbiology
por: Stres, Blaž, et al.
Publicado: (2019)

Metabolic aspects of hepatitis C virus
por: El-Kassas, Mohamed, et al.
Publicado: (2022)

New hope for hepatitis C virus: Summary of global epidemiologic changes and novel innovations over 20 years
por: Dennis, Brittany B, et al.
Publicado: (2021)

Hepatocellular carcinoma in patients with metabolic dysfunction-associated fatty liver disease: Can we stratify at-risk populations?
por: Fassio, Eduardo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_j0krj1csup315v3lsjfpp5dhdp